Structural Diversity of Copper(II) Complexes with N-(2-Pyridyl)Imidazolidin-2-Ones(Thiones) and Their in Vitro Antitumor Activity
Six series of structurally different mono- and binuclear copper(II) complexes 5–10 were obtained by reacting N-(2-pyridyl)imidazolidin-2-ones (1a–l), N,N'-bis(2-pyridyl)imidazolidin-2-ones (2a,b), N-acyl-N'(2-pyridyl)imidazolodin-2-ones (3a–j) and N-(2-pyridyl)imidazolidine-2-thiones (4a...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2014-10-01
|
Series: | Molecules |
Subjects: | |
Online Access: | http://www.mdpi.com/1420-3049/19/10/17026 |
_version_ | 1818480320986480640 |
---|---|
author | Łukasz Balewski Franciszek Sączewski Patrick J. Bednarski Maria Gdaniec Ewa Borys Anna Makowska |
author_facet | Łukasz Balewski Franciszek Sączewski Patrick J. Bednarski Maria Gdaniec Ewa Borys Anna Makowska |
author_sort | Łukasz Balewski |
collection | DOAJ |
description | Six series of structurally different mono- and binuclear copper(II) complexes 5–10 were obtained by reacting N-(2-pyridyl)imidazolidin-2-ones (1a–l), N,N'-bis(2-pyridyl)imidazolidin-2-ones (2a,b), N-acyl-N'(2-pyridyl)imidazolodin-2-ones (3a–j) and N-(2-pyridyl)imidazolidine-2-thiones (4a–g) with copper(II) chloride at an ambient temperature. The coordination modes of the complexes obtained were established by elemental analysis, IR spectroscopic data and single crystal X-ray diffraction studies. The in vitro cytotoxic activities of both the free ligands and copper(II) complexes were evaluated using a crystal violet microtiter plate assay on five human tumor cell lines: LCLC-103H, A-427, SISO, RT-4 and DAN-G. The free ligands 1–4 at concentration attainable in cancer cells of 20 μM showed no meaningful cytotoxic effect with cell viability in the range of 88%–100%. The most potent copper(II) complex of 1-(6-ethoxy-2-pyridyl)imidazolidin-2-one (6b) exhibited selective cytotoxicity against A-427 lung cancer cell line, while the complexes of 1-(5-methyl-2-pyridyl)imidazolidine-2-thione (5h) and 1-(4-tert-butyl-2-pyridyl)imidazolidine-2-thione (5j) showed cytostatic effect against a whole panel of five human tumor cell lines. In conclusion, the only complexes that showed remarkably increased activity in comparison to the free ligands were those obtained from N-(2-pyridyl)imidazolidine-2-thiones 4c and 4e substituted with alkyl group at position 4 or 5 of pyridine ring. |
first_indexed | 2024-12-10T11:21:55Z |
format | Article |
id | doaj.art-2088907406db403f9d05f52686f5e406 |
institution | Directory Open Access Journal |
issn | 1420-3049 |
language | English |
last_indexed | 2024-12-10T11:21:55Z |
publishDate | 2014-10-01 |
publisher | MDPI AG |
record_format | Article |
series | Molecules |
spelling | doaj.art-2088907406db403f9d05f52686f5e4062022-12-22T01:50:54ZengMDPI AGMolecules1420-30492014-10-011910170261705110.3390/molecules191017026molecules191017026Structural Diversity of Copper(II) Complexes with N-(2-Pyridyl)Imidazolidin-2-Ones(Thiones) and Their in Vitro Antitumor ActivityŁukasz Balewski0Franciszek Sączewski1Patrick J. Bednarski2Maria Gdaniec3Ewa Borys4Anna Makowska5Department of Chemical Technology of Drugs, Faculty of Pharmacy, Medical University of Gdańsk, 80-416 Gdańsk, PolandDepartment of Chemical Technology of Drugs, Faculty of Pharmacy, Medical University of Gdańsk, 80-416 Gdańsk, PolandDepartment of Pharmaceutical and Medicinal Chemistry, Institute of Pharmacy, University of Greifswald, L.-F.-Jahn Str., D-17489 Greifswald, GermanyFaculty of Chemistry, A. Mickiewicz University, 60-780 Poznań, PolandDepartment of Chemical Technology of Drugs, Faculty of Pharmacy, Medical University of Gdańsk, 80-416 Gdańsk, PolandDepartment of Chemical Technology of Drugs, Faculty of Pharmacy, Medical University of Gdańsk, 80-416 Gdańsk, PolandSix series of structurally different mono- and binuclear copper(II) complexes 5–10 were obtained by reacting N-(2-pyridyl)imidazolidin-2-ones (1a–l), N,N'-bis(2-pyridyl)imidazolidin-2-ones (2a,b), N-acyl-N'(2-pyridyl)imidazolodin-2-ones (3a–j) and N-(2-pyridyl)imidazolidine-2-thiones (4a–g) with copper(II) chloride at an ambient temperature. The coordination modes of the complexes obtained were established by elemental analysis, IR spectroscopic data and single crystal X-ray diffraction studies. The in vitro cytotoxic activities of both the free ligands and copper(II) complexes were evaluated using a crystal violet microtiter plate assay on five human tumor cell lines: LCLC-103H, A-427, SISO, RT-4 and DAN-G. The free ligands 1–4 at concentration attainable in cancer cells of 20 μM showed no meaningful cytotoxic effect with cell viability in the range of 88%–100%. The most potent copper(II) complex of 1-(6-ethoxy-2-pyridyl)imidazolidin-2-one (6b) exhibited selective cytotoxicity against A-427 lung cancer cell line, while the complexes of 1-(5-methyl-2-pyridyl)imidazolidine-2-thione (5h) and 1-(4-tert-butyl-2-pyridyl)imidazolidine-2-thione (5j) showed cytostatic effect against a whole panel of five human tumor cell lines. In conclusion, the only complexes that showed remarkably increased activity in comparison to the free ligands were those obtained from N-(2-pyridyl)imidazolidine-2-thiones 4c and 4e substituted with alkyl group at position 4 or 5 of pyridine ring.http://www.mdpi.com/1420-3049/19/10/170261-(2-pyridyl)imidazolidin-2-ones1-(2-pyridyl)imidazolidine-2-thionescopper(II) complexesX-ray crystal structure analysis in vitro antitumor activity |
spellingShingle | Łukasz Balewski Franciszek Sączewski Patrick J. Bednarski Maria Gdaniec Ewa Borys Anna Makowska Structural Diversity of Copper(II) Complexes with N-(2-Pyridyl)Imidazolidin-2-Ones(Thiones) and Their in Vitro Antitumor Activity Molecules 1-(2-pyridyl)imidazolidin-2-ones 1-(2-pyridyl)imidazolidine-2-thiones copper(II) complexes X-ray crystal structure analysis in vitro antitumor activity |
title | Structural Diversity of Copper(II) Complexes with N-(2-Pyridyl)Imidazolidin-2-Ones(Thiones) and Their in Vitro Antitumor Activity |
title_full | Structural Diversity of Copper(II) Complexes with N-(2-Pyridyl)Imidazolidin-2-Ones(Thiones) and Their in Vitro Antitumor Activity |
title_fullStr | Structural Diversity of Copper(II) Complexes with N-(2-Pyridyl)Imidazolidin-2-Ones(Thiones) and Their in Vitro Antitumor Activity |
title_full_unstemmed | Structural Diversity of Copper(II) Complexes with N-(2-Pyridyl)Imidazolidin-2-Ones(Thiones) and Their in Vitro Antitumor Activity |
title_short | Structural Diversity of Copper(II) Complexes with N-(2-Pyridyl)Imidazolidin-2-Ones(Thiones) and Their in Vitro Antitumor Activity |
title_sort | structural diversity of copper ii complexes with n 2 pyridyl imidazolidin 2 ones thiones and their in vitro antitumor activity |
topic | 1-(2-pyridyl)imidazolidin-2-ones 1-(2-pyridyl)imidazolidine-2-thiones copper(II) complexes X-ray crystal structure analysis in vitro antitumor activity |
url | http://www.mdpi.com/1420-3049/19/10/17026 |
work_keys_str_mv | AT łukaszbalewski structuraldiversityofcopperiicomplexeswithn2pyridylimidazolidin2onesthionesandtheirinvitroantitumoractivity AT franciszeksaczewski structuraldiversityofcopperiicomplexeswithn2pyridylimidazolidin2onesthionesandtheirinvitroantitumoractivity AT patrickjbednarski structuraldiversityofcopperiicomplexeswithn2pyridylimidazolidin2onesthionesandtheirinvitroantitumoractivity AT mariagdaniec structuraldiversityofcopperiicomplexeswithn2pyridylimidazolidin2onesthionesandtheirinvitroantitumoractivity AT ewaborys structuraldiversityofcopperiicomplexeswithn2pyridylimidazolidin2onesthionesandtheirinvitroantitumoractivity AT annamakowska structuraldiversityofcopperiicomplexeswithn2pyridylimidazolidin2onesthionesandtheirinvitroantitumoractivity |